Great progress in the scientific research of Rabdosia rubescens
-
Last Update: 2012-06-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to Chinese medical economists, the total scale of OTC antipyretic and detoxifying drug market in China is up to 100 billion yuan It can be considered that the future market of Rabdosia rubescens, as the latecomer of traditional Chinese medicine anti infective drug, is optimistic Secondly, the most potential development value of Rabdosia rubescens lies in its anti-tumor effect (especially digestive tract tumor) Therefore, it has become an important new topic in the field of medicine science and technology to develop the new use of Rabdosia rubescens as soon as possible and make it a new anticancer drug after paclitaxel There are abundant resources of Rabdosia rubescens in China Some experts believe that Rabdosia rubescens will become a new export best-selling product in the future if the development of Rabdosia rubescens enters the scale To sum up, Rabdosia rubescens is expected to become a new plant anti infective and anti-cancer drug The diversity of preparations will make Rabdosia rubescens beyond taxol and become the later comer of natural drugs at home and abroad.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
